Results 241 to 250 of about 6,659,971 (307)

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Optimization of fluidized bed drying process parameters and quality evaluation of ready to use onion slices. [PDF]

open access: yesSci Rep
Faisal S   +11 more
europepmc   +1 more source

Quality Evaluation of High-Polyphenol Vinegars Produced from Various Romanian Plum Cultivars. [PDF]

open access: yesFoods
Todașcă MC   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy